Clinical Trial 45139

Sherman Oaks, CA 91403


This study compares the currently available medication for psoriasis called Ustekinumab (Brand name Stellara) to a new similar medication.  This is a double blind study but there is NO Placebo which means ALL patients receive treatment with either the investigational medication or Ustekinumab!  The study is 52 weeks long with a total of 9 visits. Qualified patients will be coming in for visits approximately once every 8-12 weeks on average.

Qualified Participants Must:

• Adult subjects including men and women between 18 to 75 years of age with moderate to sever plaque Psoriasis: Pregnant women are excluded from this trial
• Even if you are on a current medication which is not fully effective in controlling your psoriasis symptoms you can still qualify for this trial

Qualified Participants May Receive:

Participants will receive compensation for time and travel for each visit.  They will be evaluated by one of our physicians with a complete history and physical exam.  Blood work will also be done for complete health evaluation.  All exams and testing are complimentary and NO Health Insurance Necessary.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.